AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-92
Results: 1-25/92

Authors: RUMMEL M KNUTH A HOSSFELD D BERGMANN L HOELZER D MITROU PS
Citation: M. Rummel et al., 2-CDA IN THE TREATMENT OF PREVIOUSLY UNTREATED LOW-GRADE NON-HODGKINS-LYMPHOMAS - FINAL RESULTS, Annals of oncology, 9, 1998, pp. 517-517

Authors: KARAKAS T MAURER U WEIDMANN E MIETHING CC HOELZER D BERGMANN L
Citation: T. Karakas et al., HIGH EXPRESSION OF BCL-2 MESSENGER-RNA AS A DETERMINANT OF POOR-PROGNOSIS IN ACUTE MYELOID-LEUKEMIA, Annals of oncology, 9(2), 1998, pp. 159-165

Authors: BANGERTER M MOOG F BUCHMANN I KOTZERKE J GRIESSHAMMER M HAFNER M ELSNER K FRICKHOFEN N RESKE SN BERGMANN L
Citation: M. Bangerter et al., WHOLE-BODY 2-[F-18]-FLUORO-2-DEOXY-D-GLUCOSE POSITRON-EMISSION-TOMOGRAPHY (FDC-PET) FOR ACCURATE STAGING OF HODGKINS-DISEASE, Annals of oncology, 9(10), 1998, pp. 1117-1122

Authors: VONSCHILLING C BERGMANN L WAGNER T TESCH H SCHULTZE W PESCHEL C
Citation: C. Vonschilling et al., THE VALUE OF IFOSFAMIDE IN THE TREATMENT OF MULTIPLE-MYELOMA, Onkologie, 21, 1998, pp. 30-33

Authors: MARTIN H ATTA J FAUTH F OTTMANN OG OTT MG WASSMANN B BERGMANN L KNAUF W GRAMATZKI M ZANDER A BUNJES D ARNOLD R HOELZER D
Citation: H. Martin et al., AUTOLOGOUS BMT PBSCT IN PATIENTS WITH BCR-ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA/, Bone marrow transplantation, 21, 1998, pp. 5-5

Authors: KROGER M BUNJES D BERGMANN L
Citation: M. Kroger et al., COMBINED INHALATION-THERAPY (CIT) MAY PREVENT TOXIC AIRWAY DAMAGE (TAD) AFTER HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 309-309

Authors: BUNJES D VONHARSDORF S DUYSTER J DUNCKER C BERGMANN L
Citation: D. Bunjes et al., MYCOPHENOLATE MOFETIL - A POTENT NEW DRUG FOR THE TREATMENT OF CHRONIC GRAFT-VS-HOST-DISEASE WITH A FAVORABLE TOXICITY PROFILE, Bone marrow transplantation, 21, 1998, pp. 404-404

Authors: KLIESCH S BEHRE HM HERTLE L BERGMANN L
Citation: S. Kliesch et al., ALTERATION OF SERTOLI-CELL DIFFERENTIATION IN THE PRESENCE OF CARCINOMA IN-SITU IN HUMAN TESTES, The Journal of urology, 160(5), 1998, pp. 1894-1898

Authors: KRAUTER J PETER W PASCHEBERG U HEINZE B BERGMANN L HOELZER D LUBBERT M SCHLIMOK G ARNOLD R KIRCHNER H PORT M GANSER A HEIL G
Citation: J. Krauter et al., DETECTION OF KARYOTYPIC ABERRATIONS IN ACUTE MYELOBLASTIC-LEUKEMIA - A PROSPECTIVE COMPARISON BETWEEN PCR FISH AND STANDARD CYTOGENETICS IN140 PATIENTS WITH DE-NOVO AML/, British Journal of Haematology, 103(1), 1998, pp. 72-78

Authors: KRAUTER J PASCHEBERG U HEINZE B BERGMANN L HOELZER D LUBBERT M SCHLIMOK G ARNOLD R KIRCHNER H PORT M GANSER A HELL G
Citation: J. Krauter et al., DETECTION OF CHROMOSOMAL-ABERRATIONS IN AML - COMPARISON OF RT-PCR FISH WITH STANDARD CYTOGENETICS/, British Journal of Haematology, 102(1), 1998, pp. 98-98

Authors: BANGERTER M MOOG F GRIESSHAMMER M RESKE SN BERGMANN L
Citation: M. Bangerter et al., ROLE OF WHOLE-BODY FDG-PET IN PREDICTING RELAPSE IN RESIDUAL MASSES AFTER TREATMENT OF LYMPHOMA, British Journal of Haematology, 102(1), 1998, pp. 148-148

Authors: HEIL G KRAUTER J BERGMANN L HOELZER D HOSSFELD D MERTELSMANN R NOENS L SCHLIMOK G PORT M SCHWAB G GANSER A
Citation: G. Heil et al., RISK ADAPTED INDUCTION AND CONSOLIDATION THERAPY INCLUDING AUTOLOGOUSPERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) IN ADULT DE-NOVO AML PATIENTS, British Journal of Haematology, 102(1), 1998, pp. 150-150

Authors: BERGMANN L MAURER U WEIDMANN E
Citation: L. Bergmann et al., WILMS-TUMOR GENE-EXPRESSION IN ACUTE MYELOID LEUKEMIAS, Leukemia & lymphoma, 25(5-6), 1997, pp. 435-443

Authors: BERGMANN L
Citation: L. Bergmann, THE RELEVANCE OF THE BCL-2 GENE AND WILMS-TUMOR GENE FOR THE LONG-TERM PROGNOSIS OF ACUTE MYELOID-LEUKEMIA, European journal of cancer, 33, 1997, pp. 1-1

Authors: HARTMANN C BERGMANN L
Citation: C. Hartmann et L. Bergmann, SPECULAR MICROSCOPY - FROM SPECULATIVE TO SPECTACULAR MICROSCOPY, German journal of ophthalmology, 5(6), 1997, pp. 496-503

Authors: GEISSLER RG BERGMANN L HACKER H KNUPP B WALKER B HOELZER D
Citation: Rg. Geissler et al., SEVERE CENTRAL NERVOUS ADVERSE EFFECT OF INTRATHECAL CHEMOTHERAPY IN A 16-YR-OLD PATIENT WITH BURKITTS TYPE LYMPHOMA, European journal of haematology, 58(4), 1997, pp. 286-288

Authors: WEIDMANN E BRIEGER J KARAKAS T MAURER U PASCHEBERG U HOELZER D MITROU PS BERGMANN L
Citation: E. Weidmann et al., ESTABLISHMENT AND CHARACTERIZATION OF A NEW, FACTOR-INDEPENDENT ACUTEMYELOID-LEUKEMIA LINE DESIGNATED EI501, Leukemia, 11(5), 1997, pp. 709-713

Authors: BERGMANN L
Citation: L. Bergmann, PRESENT STATUS OF PURINE ANALOGS IN THE THERAPY OF CHRONIC LYMPHOCYTIC LEUKEMIAS, Leukemia, 11, 1997, pp. 29-34

Authors: BERGMANN L
Citation: L. Bergmann, PURINE ANALOGS IN THE THERAPY OF CHRONIC LYMPHOCYTIC-LEUKEMIA AND INDOLENT LYMPHOMAS, Onkologie, 20(4), 1997, pp. 278-286

Authors: RUMMEL M SCHENK M RENNER C KNUTH A JOSTEN K REINHARDT U RENDENBACH B PIELKEN HJ WOJATSCHEK C LENGFELDER E MITROU PS HOELZER D BERGMANN L
Citation: M. Rummel et al., FLUDARABINE PLUS EPIRUBICIN IN UNTREATED OR MINIMAL PRETREATED PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS OF A PHASE-II STUDY, Onkologie, 20(4), 1997, pp. 328-331

Authors: MAURER U BRIEGER J WEIDMANN E MITROU PS HOELZER D BERGMANN L
Citation: U. Maurer et al., THE WILMS-TUMOR GENE IS EXPRESSED IN A SUBSET OF CD34(-REGULATED EARLY IN THE COURSE OF DIFFERENTIATION IN-VITRO() PROGENITORS AND DOWN), Experimental hematology, 25(9), 1997, pp. 945-950

Authors: NAGASHIMA I BERGMANN L ALSINA AE SCHWEIZER RT
Citation: I. Nagashima et al., AUXILIARY HETEROTOPIC PARTIAL LIVER-TRANSPLANTATION IN PIGS WITH ACUTE ISCHEMIC LIVER-FAILURE, Hepato-gastroenterology, 44(17), 1997, pp. 1426-1431

Authors: BERGMANN L MIETHING C MAURER U BRIEGER J KARAKAS T WEIDMANN E HOELZER D
Citation: L. Bergmann et al., HIGH-LEVELS OF WILMS-TUMOR GENE (WT1) MESSENGER-RNA IN ACUTE MYELOID LEUKEMIAS ARE ASSOCIATED WITH A WORSE LONG-TERM OUTCOME, Blood, 90(3), 1997, pp. 1217-1225

Authors: MAURER U WEIDMANN E KRAPOHL A SCHNEIDER B KARAKAS T HOELZER D BERGMANN L
Citation: U. Maurer et al., CONSTITUTIVE EXPRESSION OF WILMS-TUMOR GENE IN K562 DOES NOT ALTER TPA-INDUCED DIFFERENTIATION, Blood, 90(10), 1997, pp. 3775-3775

Authors: KARAKAS T MAURER U WEIDMANN E HOELZER D BERGMANN L
Citation: T. Karakas et al., HIGH EXPRESSION OF BCL-2 MESSENGER-RNA AS A DETERMINANT OF POOR-PROGNOSIS IN ACUTE MYELOID-LEUKEMIA, Blood, 90(10), 1997, pp. 287-287
Risultati: 1-25 | 26-50 | 51-75 | 76-92